CD4 and COVID-19: The utility of the TDS assay was particularly apparent for COVID-19 patients, where severe disease was associated with abundant CD8 and CD4 TEM cells in G1 and in S-G2/M, and γδ T cells in G1 (figure 93D-E and [880]).